Skip to main content

Table 2 Clinical characteristics of before and post-transplant patients

From: The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients

 

Transplant stable (n = 13)

Acute antibody mediated acute rejection (n = 8)

Acute rejection (n = 7)

Chronic rejection (n = 7)

 

Before

After

Before

After

Before

After

Before

After

BUN (mmol/L)

17.5 (7.2–32.8)

7.4* (3.7–10.6)

16.2 (10.1–28.4)

29.1* (22.3–38.9)

16.2 (14.4–20.6)

25.2* (17.9–34.7)

16.5 (9.2–22.6)

18.3* (13.5–26.8)

Cr (umol/L)

779 (499–1790)

130* (72–352)

798 (739–1682)

1387* (1098–1786)

789 (762–1562)

987* (794–1682)

786 (698–1492)

578* (512–755)

eGFR (ml/min)

20 (8–67)

88* (59–101)

27 (8–62)

9* (4–13)

21 (9–59)

12* (6–24)

24 (9–51)

18* (5–35)

WBC (×109/L)

9.8 (8.5–13.4)

7.9* (6.3–9.7)

9.7 (8.9–13.9)

17.7* (11.8–19.6)

9.6 (8.8–11.6)

13.1* (9.9–16.2)

9.7 (8.6–13.2)

11.7* (9.6–13.7)

PBMCs (×109/L)

1.7 (1.1–2.9)

0.8* (0.6–1.0)

1.7 (1.3–3.3)

0.3* (0.1–0.6)

1.9 (1.4–3.1)

0.7* (0.4–1.0)

1.7 (1.1–2.7)

0.7* (0.9–1.2)

RBC (×1012/L)

2.4 (2.1–2.7)

3.1* (2.6–3.3)

2.0 (1.7–2.5)

1.5* (1.3–2.0)

2.1 (1.9–3.1)

1.9* (1.7–2.3)

2.0 (1.9–2.9)

2.3* (2.0–2.8)

Hb (g/L)

86.0 (73.0–99.0)

97.0* (88.0–103.0)

82.0 (66.0–91.0)

73.0* (61.0–77.0)

87.0 (69.0–103.0)

78.0* (67.0–89.0)

84.0 (69.0–107)

91.0* (80.0–110.0)

  1. Data are expressed as median (range) or real case numbers
  2. * P < 0.05 vs, before transplant rejection